Company Filing History:
Years Active: 1994-1996
Title: **Inventor Spotlight: David F Bishop**
Introduction:
David F Bishop is a prolific inventor based in New York, NY, with a notable portfolio of 5 patents to his name. His groundbreaking work in the field of biologically active enzymes has positioned him as a key figure in the biotechnology industry.
Latest Patents:
One of his latest patents is on the "Cloning and expression of biologically active .alpha.-galactosidase A." This innovative invention focuses on producing significant quantities of the human .alpha.-Gal A enzyme through cloning and expression in eukaryotic host cell systems. The engineered host cells play a crucial role in the cotranslational and posttranslational modifications necessary for proper processing, such as glycosylation and phosphorylation. This active enzyme has various applications, including treating Fabry Disease and facilitating the conversion of blood group antigens.
Another notable patent by David F Bishop involves the production of human .alpha.-GalNAc through similar cloning and expression techniques. The resulting .alpha.-GalNAc enzyme can be utilized in treating Schindler disease and hydrolyzing .alpha.-N-acetylgalactosaminyl moieties in glycoconjugates.
Career Highlights:
David F Bishop has made significant contributions to the field of biotechnology through his work at institutions like Mount Sinai School of Medicine of the City University of New York and Mount Sinai School of Medicine of the City of New York. His dedication to innovation has led to the development of groundbreaking technologies that have the potential to revolutionize the healthcare industry.
Collaborations:
Throughout his career, David F Bishop has collaborated with esteemed professionals in the field, including Robert J Desnick and Yiannis A Ioannou. These collaborations have been instrumental in advancing research and development in biologically active enzymes.
Conclusion:
In conclusion, David F Bishop's inventive spirit and commitment to pushing the boundaries of biotechnology have cemented his legacy as a visionary inventor. His patents and collaborations underscore his contribution to the scientific community and his ongoing efforts to improve healthcare through innovation.